Finance

Lists
ENGN:NASDAQ
enGene Therapeutics Inc
US$1,76
+0,57%
(+0,0100) 1D
8 ຕ.ລ., 14 ໂມງ 53 ນາທີ 48 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENGN...
Open
US$1,75
High
US$1,78
Low
US$1,68
Mkt. cap
117,61 ລ້ານ
Avg. vol.
735,26 ພັນ
Volume
1,22 ລ້ານ
52-wk high
US$12,25
52-wk low
US$1,40
EPS
US$-2,08
Beta
-0,29
Shares outstanding
67,02 ລ້ານ
No. of employees
82
Open
US$1,75
High
US$1,78
Low
US$1,68
Mkt. cap
117,61 ລ້ານ
Avg. vol.
735,26 ພັນ
Volume
1,22 ລ້ານ
52-wk high
US$12,25
52-wk low
US$1,40
EPS
US$-2,08
Beta
-0,29
Shares outstanding
67,02 ລ້ານ
No. of employees
82
News stories
From web sources and news partners
About enGene Therapeutics Inc
CEO-
Employees82
Founded-
Headquarters-
SectorBiotechnology
Websiteengene.com
Analyst ratings
Based on 5 analysts giving stock ratings to ENGN in the past 3 months
Hold
Buy
1
Hold
3
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ENGN in the last 3 months.
Highest
Current US$1,76
US$4,00 (+127,92%)
Average
US$2,50 (+42,45%)
Lowest
US$2,00 (+13,96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yanan Zhu
Wells Fargo
Hold
Maintained
US$2,00
+14%
10/02/2026
David Dai
UBS
Hold
Reiterated
US$2,00
+14%
09/16/2026
Mani Foroohar
Leerink Partners
Hold
Reiterated
US$2,00
+14%
09/09/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
US$4,00
+127,9%
09/09/2026
Judah Frommer
Morgan Stanley
Sell
Maintained
-
-
08/12/2026
Michael Schmidt
Guggenheim
Hold
Maintained
-
-
06/16/2026
Leland Gershell
Oppenheimer
Hold
Maintained
-
-
05/08/2026
Sean McCutcheon
Raymond James
Buy
Maintained
US$4,00
+127,9%
05/08/2026
Allison Bratzel
Piper Sandler
Hold
Downgraded
US$4,00
+127,9%
05/08/2026
Silvan Tuerkcan
Citizens JMP
Hold
Downgraded
-
-
05/08/2026
Unknown Analyst
WBB Securities
Buy
Initiated
US$21,50
+1.125,1%
04/13/2026
Xin Yang NG‏
USmart Securities
Buy
Initiated
US$21,50
+1.125,1%
04/13/2026
Xin Yang NG‏
USmart Securities
Buy
Initiated
US$21,50
+1.125,1%
04/13/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
-
-
03/26/2026
Maury Raycroft
Jefferies
Buy
Maintained
US$28,00
+1.495,4%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ຕ.ລ. 2025
ມ.ກ. 2026
ມ.ສ. 2026
ກ.ລ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
31,72 ລ້ານ
22,26 ລ້ານ
22,20 ລ້ານ
20,09 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,76 ລ້ານ
8,93 ລ້ານ
9,77 ລ້ານ
13,92 ລ້ານ
Operating expense
39,48 ລ້ານ
31,18 ລ້ານ
31,97 ລ້ານ
34,01 ລ້ານ
Total operating expenses
39,48 ລ້ານ
31,18 ລ້ານ
31,97 ລ້ານ
34,01 ລ້ານ
Operating income
-39,48 ລ້ານ
-31,18 ລ້ານ
-31,97 ລ້ານ
-34,01 ລ້ານ
Other non operating income
448,00 ພັນ
-
-
-
EBT including unusual items
-38,38 ລ້ານ
-29,75 ລ້ານ
-30,23 ລ້ານ
-32,50 ລ້ານ
EBT excluding unusual items
-38,38 ລ້ານ
-29,26 ລ້ານ
-30,23 ລ້ານ
-32,50 ລ້ານ
Income tax expense
-497,00 ພັນ
-
-
-
Effective tax rate
1,29%
-
-
-
Other operating expenses
-
-
-
-
Net income
-37,88 ລ້ານ
-29,75 ລ້ານ
-30,23 ລ້ານ
-32,50 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-0,73
-0,44
-0,43
-0,47
Interest and investment income
1,98 ລ້ານ
2,74 ລ້ານ
2,66 ລ້ານ
2,40 ລ້ານ
Interest expense
-750,00 ພັນ
-732,00 ພັນ
-745,00 ພັນ
-843,00 ພັນ
Net interest expenses
1,22 ລ້ານ
2,01 ລ້ານ
1,92 ລ້ານ
1,56 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-39,31 ລ້ານ
-31,00 ລ້ານ
-31,79 ລ້ານ
-33,84 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google